Events

newsline
Jun 22 2007	New anti-tumour drug - "Taxolik". The anti-tumour preparation strengthening formation of stable microtubules from tubuline and oppressing their disintegration that leads to the expressed reduction of free tubuline concentration. Renders cytotoxic action on various tumoral cells of the human.
Jan 25 2007	New drug - "Bioglobin-U" : analgesic, antiphlogistic, immunomodulator. Indicated for treatment of osteochondrosis, osteoarthritis, rheumatoid arthritis.
Nov 21 2006	New dosage of "Mitolik" ( 10 ml ).
Oct 26 2006	New product - immunomodulator "Laferonum" (human recombinant alpha-2b interferon) launched.
Oct 2006	Another antitumour antibiotic "Idalik" (Idarubicine) launched.
Sep 01 2006	Human normal immunoglobulin for intravenous injections in useful dosage (50 ml) launched.
Jun 20 2006	Another antitumour antibiotic "Epilik" (Epirubicine) launched.
Jun 15 2006	New drug launched - antitumour antibiotic "Mitolik" (Mitoxantone) for injections.
Mar 23 2006	"Biolik" presents two new drugs: - antitumour antibiotic "Doxolik" for injections; - human normal immunoglobulin for intravenous injections in useful dosage (25 ml).
Nov 1 2005	"Biolik" proudly presents the new product - recombinant anti Hepatitis B vaccine (in co-operation with Heber Biotec S.A., Cuba).

© COPYRIGHT 2007 ALL RIGHTS RESERVED Biolik JSC